ArticleFrontiers in immunology2022

Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease.

Alexander M Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.